Try out PMC Labs and tell us what you think. Learn More.

Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Neurol Neurosurg Psychiatry. 1999 Sep; 67(3): 282–289.
doi: 10.1136/jnnp.67.3.282
PMCID: PMC1736520
PMID: 10449547

Physicians, subsequence and consequence

W McDonald
Author information Copyright and License information Disclaimer

Full Text

The Full Text of this article is available as a PDF (94K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Meadows SP. Blindness due to occlusive arterial disease ("visual strokes"). Trans Ophthalmol Soc U K. 1965;85:251–258. [PubMed] [Google Scholar]
  • KENNEDY C, CARTER S. Relation of optic neuritis to multiple sclerosis in children. Pediatrics. 1961 Sep;28:377–387. [PubMed] [Google Scholar]
  • HIERONS R, LYLE TK. Bilateral retrobulbar optic neuritis. Brain. 1959 Mar;82(1):56–67. [PubMed] [Google Scholar]
  • Parkin PJ, Hierons R, McDonald WI. Bilateral optic neuritis. A long-term follow-up. Brain. 1984 Sep;107(Pt 3):951–964. [PubMed] [Google Scholar]
  • Kriss A, Francis DA, Cuendet F, Halliday AM, Taylor DS, Wilson J, Keast-Butler J, Batchelor JR, McDonald WI. Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiatry. 1988 Oct;51(10):1253–1258. [PMC free article] [PubMed] [Google Scholar]
  • Haller P, Patzold U. Die Optikusneuritis im Kindesalter. Bericht über 21 Fälle. Fortschr Neurol Psychiatr Grenzgeb. 1979 Apr;47(4):209–216. [PubMed] [Google Scholar]
  • Lucchinetti CF, Kiers L, O'Duffy A, Gomez MR, Cross S, Leavitt JA, O'Brien P, Rodriguez M. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology. 1997 Nov;49(5):1413–1418. [PubMed] [Google Scholar]
  • McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry. 1992 Sep;55(9):747–752. [PMC free article] [PubMed] [Google Scholar]
  • Earl CJ, Martin B. Prognosis in optic neuritis related to age. Lancet. 1967 Jan 14;1(7481):74–76. [PubMed] [Google Scholar]
  • Gould ES, Bird AC, Leaver PK, McDonald WI. Treatmenf of optic neuritis by retrobulbar injection of triamcinolone. Br Med J. 1977 Jun 11;1(6075):1495–1497. [PMC free article] [PubMed] [Google Scholar]
  • Beck RW, Cleary PA, Anderson MM, Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992 Feb 27;326(9):581–588. [PubMed] [Google Scholar]
  • Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology. 1995 Feb;45(2):244–250. [PubMed] [Google Scholar]
  • Miller DH, Newton MR, van der Poel JC, du Boulay EP, Halliday AM, Kendall BE, Johnson G, MacManus DG, Moseley IF, McDonald WI. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology. 1988 Feb;38(2):175–179. [PubMed] [Google Scholar]
  • Kapoor R, Miller DH, Jones SJ, Plant GT, Brusa A, Gass A, Hawkins CP, Page R, Wood NW, Compston DA, et al. Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology. 1998 Jan;50(1):230–237. [PubMed] [Google Scholar]
  • Bradley WG, Whitty CW. Acute optic neuritis: prognosis for development of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1968 Feb;31(1):10–18. [PMC free article] [PubMed] [Google Scholar]
  • Francis DA, Compston DA, Batchelor JR, McDonald WI. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry. 1987 Jun;50(6):758–765. [PMC free article] [PubMed] [Google Scholar]
  • Rizzo JF, 3rd, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology. 1988 Feb;38(2):185–190. [PubMed] [Google Scholar]
  • Sandberg-Wollheim M, Bynke H, Cronqvist S, Holtås S, Platz P, Ryder LP. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol. 1990 Apr;27(4):386–393. [PubMed] [Google Scholar]
  • Compston DA. The dissemination of multiple sclerosis. The Langdon-Brown lecture 1989. J R Coll Physicians Lond. 1990 Jul;24(3):207–218. [PMC free article] [PubMed] [Google Scholar]
  • IVERS RR, GOLDSTEIN NP. MULTIPLE SCLEROSIS: A CURRENT APPRAISAL OF SYMPTOMS AND SIGNS. Proc Staff Meet Mayo Clin. 1963 Oct 9;38:457–466. [PubMed] [Google Scholar]
  • Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci. 1981 Feb;49(2):253–271. [PubMed] [Google Scholar]
  • Kurland LT, Beebe GW, Kurtzke JF, Nagler B, Auth TL, Lessell S, Nefzger MD. Studies on the natural history of multiple sclerosis. 2. The progression of optic neuritis to multiple sclerosis. Acta Neurol Scand. 1966;42(Suppl):157+–157+. [PubMed] [Google Scholar]
  • TAUB RG, RUCKER CW. The relationship of retrobulbar neuritis to multiple sclerosis. Am J Ophthalmol. 1954 Apr;37(4):494–497. [PubMed] [Google Scholar]
  • Collis WJ. Acute unilateral retrobulbar neuritis. Arch Neurol. 1965 Oct;13(4):409–412. [PubMed] [Google Scholar]
  • Cohen MM, Lessell S, Wolf PA. A prospective study of the risk of developing multiple sclerosis in uncomplicated optic neuritis. Neurology. 1979 Feb;29(2):208–213. [PubMed] [Google Scholar]
  • Hutchinson WM. Acute optic neuritis and the prognosis for multiple sclerosis. J Neurol Neurosurg Psychiatry. 1976 Mar;39(3):283–289. [PMC free article] [PubMed] [Google Scholar]
  • Compston DA, Batchelor JR, Earl CJ, McDonald WI. Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain. 1978 Sep;101(3):495–511. [PubMed] [Google Scholar]
  • Kinnunen E. The incidence of optic neuritis and its prognosis for multiple sclerosis. Acta Neurol Scand. 1983 Dec;68(6):371–377. [PubMed] [Google Scholar]
  • Rischbieth RH. Retrobulbar neuritis in the state of South Australia. Proc Aust Assoc Neurol. 1968;5(3):573–575. [PubMed] [Google Scholar]
  • Landy PJ. A prospective study of the risk of developing multiple sclerosis in optic neuritis in a tropical and sub-tropical area. J Neurol Neurosurg Psychiatry. 1983 Jul;46(7):659–661. [PMC free article] [PubMed] [Google Scholar]
  • Hely MA, McManis PG, Doran TJ, Walsh JC, McLeod JG. Acute optic neuritis: a prospective study of risk factors for multiple sclerosis. J Neurol Neurosurg Psychiatry. 1986 Oct;49(10):1125–1130. [PMC free article] [PubMed] [Google Scholar]
  • Isayama Y, Takahashi T, Shimoyoma T, Yamadori A. Acute optic neuritis and multiple sclerosis. Neurology. 1982 Jan;32(1):73–76. [PubMed] [Google Scholar]
  • Moulin D, Paty DW, Ebers GC. The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis. Brain. 1983 Dec;106(Pt 4):809–816. [PubMed] [Google Scholar]
  • Söderström M, Ya-Ping J, Hillert J, Link H. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology. 1998 Mar;50(3):708–714. [PubMed] [Google Scholar]
  • Lightman S, McDonald WI, Bird AC, Francis DA, Hoskins A, Batchelor JR, Halliday AM. Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain. 1987 Apr;110(Pt 2):405–414. [PubMed] [Google Scholar]
  • Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol. 1996 Jan;39(1):6–16. [PubMed] [Google Scholar]
  • Miller DH, Ormerod IE, McDonald WI, MacManus DG, Kendall BE, Kingsley DP, Moseley IF. The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry. 1988 Dec;51(12):1569–1571. [PMC free article] [PubMed] [Google Scholar]
  • O'Riordan JI, Thompson AJ, Kingsley DP, MacManus DG, Kendall BE, Rudge P, McDonald WI, Miller DH. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain. 1998 Mar;121(Pt 3):495–503. [PubMed] [Google Scholar]
  • Morrissey SP, Borruat FX, Miller DH, Moseley IF, Sweeney MG, Govan GG, Kelly MA, Francis DA, Harding AE, McDonald WI. Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):70–74. [PMC free article] [PubMed] [Google Scholar]
  • Stewart WA, Hall LD, Berry K, Paty DW. Correlation between NMR scan and brain slice data in multiple sclerosis. Lancet. 1984 Aug 18;2(8399):412–412. [PubMed] [Google Scholar]
  • Ormerod IE, Miller DH, McDonald WI, du Boulay EP, Rudge P, Kendall BE, Moseley IF, Johnson G, Tofts PS, Halliday AM, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain. 1987 Dec;110(Pt 6):1579–1616. [PubMed] [Google Scholar]
  • Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol. 1993 Nov;34(5):661–669. [PubMed] [Google Scholar]
  • Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology. 1991 Aug;180(2):467–474. [PubMed] [Google Scholar]
  • Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, Rudge P, McDonald WI. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain. 1990 Oct;113(Pt 5):1477–1489. [PubMed] [Google Scholar]
  • Willoughby EW, Grochowski E, Li DK, Oger J, Kastrukoff LF, Paty DW. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol. 1989 Jan;25(1):43–49. [PubMed] [Google Scholar]
  • Miller DH, Rudge P, Johnson G, Kendall BE, Macmanus DG, Moseley IF, Barnes D, McDonald WI. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain. 1988 Aug;111(Pt 4):927–939. [PubMed] [Google Scholar]
  • Larsson HB, Frederiksen J, Kjaer L, Henriksen O, Olesen J. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med. 1988 May;7(1):43–55. [PubMed] [Google Scholar]
  • Barnes D, McDonald WI, Landon DN, Johnson G. The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain. 1988 Feb;111(Pt 1):83–94. [PubMed] [Google Scholar]
  • Barnes D, Munro PM, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain. 1991 Jun;114(Pt 3):1271–1280. [PubMed] [Google Scholar]
  • Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, McDonald WI. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 1994 Feb;117(Pt 1):49–58. [PubMed] [Google Scholar]
  • Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG, Jones SJ, Barrett G, Kendall BE, Moseley IF, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain. 1991 Dec;114(Pt 6):2437–2450. [PubMed] [Google Scholar]
  • MCDONALD WI. THE EFFECTS OF EXPERIMENTAL DEMYELINATION ON CONDUCTION IN PERIPHERAL NERVE: A HISTOLOGICAL AND ELECTROPHYSIOLOGICAL STUDY. II. ELECTROPHYSIOLOGICAL OBSERVATIONS. Brain. 1963 Sep;86:501–524. [PubMed] [Google Scholar]
  • McDonald WI, Sears TA. The effects of experimental demyelination on conduction in the central nervous system. Brain. 1970;93(3):583–598. [PubMed] [Google Scholar]
  • Redford EJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain. 1997 Dec;120(Pt 12):2149–2157. [PubMed] [Google Scholar]
  • England JD, Gamboni F, Levinson SR, Finger TE. Changed distribution of sodium channels along demyelinated axons. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6777–6780. [PMC free article] [PubMed] [Google Scholar]
  • Black JA, Felts P, Smith KJ, Kocsis JD, Waxman SG. Distribution of sodium channels in chronically demyelinated spinal cord axons: immuno-ultrastructural localization and electrophysiological observations. Brain Res. 1991 Mar 22;544(1):59–70. [PubMed] [Google Scholar]
  • Bostock H, Sears TA. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physiol. 1978 Jul;280:273–301. [PMC free article] [PubMed] [Google Scholar]
  • Moll C, Mourre C, Lazdunski M, Ulrich J. Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res. 1991 Aug 16;556(2):311–316. [PubMed] [Google Scholar]
  • Prineas JW, Connell F. Remyelination in multiple sclerosis. Ann Neurol. 1979 Jan;5(1):22–31. [PubMed] [Google Scholar]
  • Ozawa K, Suchanek G, Breitschopf H, Brück W, Budka H, Jellinger K, Lassmann H. Patterns of oligodendroglia pathology in multiple sclerosis. Brain. 1994 Dec;117(Pt 6):1311–1322. [PubMed] [Google Scholar]
  • Jones SJ. Visual evoked potentials after optic neuritis. Effect of time interval, age and disease dissemination. J Neurol. 1993 Sep;240(8):489–494. [PubMed] [Google Scholar]
  • Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol. 1993 Jun;111(6):773–775. [PubMed] [Google Scholar]
  • Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med. 1993 Dec 9;329(24):1764–1769. [PubMed] [Google Scholar]
  • Silberberg DH. Corticosteroids and optic neuritis. N Engl J Med. 1993 Dec 9;329(24):1808–1810. [PubMed] [Google Scholar]
  • Beck RW. The optic neuritis treatment trial: three-year follow-up results. Arch Ophthalmol. 1995 Feb;113(2):136–137. [PubMed] [Google Scholar]
  • Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. Brain. 1991 Apr;114(Pt 2):1057–1067. [PubMed] [Google Scholar]
  • Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993 Feb;116(Pt 1):117–134. [PubMed] [Google Scholar]
Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group